Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UIOLU:LX

591.9500 USD 0.00000.00%

As of 03:04:13 ET on 01/29/2015.

Snapshot for UBS Lux Equity Fund - Biotech USD (UIOLU)

Open: - High - Low: - Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 384.3700 - 609.8300 Beta vs NSESWRLD: 0.8028

ETF Chart for UIOLU

No chart data available.
  • UIOLU:LX 591.9500
  • 1D
  • 1M
  • 1Y
591.9500
Interactive UIOLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UIOLU

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: Telephone: 352-44-10-10-1 Tel
Managers: ANGUS W H MUIRHEAD / NATHALIE LOTSCHER PETRUS
Web Site: www.ubs.com

Fundamentals for UIOLU

NAV -
Assets (M) (on 2015-01-29) 1,665.8690
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UIOLU

No dividends reported

Performance for UIOLU

1-Month +7.87% 1-Year +32.24%
3-Month +9.45% 3-Year +41.28%
Year To Date +5.69% 5-Year +28.13%
Expense Ratio -

Top Fund Holdings for UIOLU

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 1,102,400 117,350,480 9.900%
Biogen Idec Inc 347,500 114,956,475 9.698%
Amgen Inc 767,214 107,762,878 9.091%
Celgene Corp 981,820 93,056,900 7.851%
Regeneron Pharmaceuticals Inc 162,200 58,476,344 4.933%
Vertex Pharmaceuticals Inc 518,100 58,187,811 4.909%
BioMarin Pharmaceutical Inc 801,300 57,821,808 4.878%
Alexion Pharmaceuticals Inc 344,500 57,124,990 4.819%
Medivation Inc 538,500 53,241,495 4.492%
Alkermes PLC 923,293 39,581,571 3.339%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil